161 results on '"HA, hemagglutinin"'
Search Results
152. Immune camouflage: relevance to vaccines and human immunology.
- Author
-
De Groot AS, Moise L, Liu R, Gutierrez AH, Tassone R, Bailey-Kellogg C, and Martin W
- Subjects
- Cross Reactions, Epitopes, T-Lymphocyte, Humans, Immune Tolerance, Influenza A Virus, H7N9 Subtype immunology, Receptors, Antigen, T-Cell physiology, Immune Evasion, Vaccines immunology
- Abstract
High strain sequence variability, interference with innate immune mechanisms, and epitope deletion are all examples of strategies that pathogens have evolved to subvert host defenses. To this list we would add another strategy: immune camouflage. Pathogens whose epitope sequences are cross-conserved with multiple human proteins at the TCR-facing residues may be exploiting "ignorance and tolerance," which are mechanisms by which mature T cells avoid immune responses to self-antigens. By adopting amino acid configurations that may be recognized by autologous regulatory T cells, pathogens may be actively suppressing protective immunity. Using the new JanusMatrix TCR-homology-mapping tool, we have identified several such 'camouflaged' tolerizing epitopes that are present in the viral genomes of pathogens such as emerging H7N9 influenza. Thus in addition to the overall low number of T helper epitopes that is present in H7 hemaglutinin (as described previously, see http://dx.doi.org/10.4161/hv.24939), the presence of such tolerizing epitopes in H7N9 could explain why, in recent vaccine trials, whole H7N9-HA was poorly immunogenic and associated with low seroconversion rates (see http://dx.doi.org/10.4161/hv.28135). In this commentary, we provide an overview of the immunoinformatics process leading to the discovery of tolerizing epitopes in pathogen genomic sequences, provide a brief summary of laboratory data that validates the discovery, and point the way forward. Removal of viral, bacterial and parasite tolerizing epitopes may permit researchers to develop more effective vaccines and immunotherapeutics in the future.
- Published
- 2014
- Full Text
- View/download PDF
153. Meeting report VLPNPV: Session 6: Development and characterization.
- Author
-
Rutkowska D
- Subjects
- Animals, Antigens, Viral immunology, Drug Delivery Systems methods, Humans, Influenza A Virus, H7N9 Subtype immunology, Influenza, Human immunology, Influenza, Human prevention & control, Mice, Nanoparticles, Rotavirus immunology, Rotavirus Infections immunology, Rotavirus Infections prevention & control, Vaccines, Virus-Like Particle therapeutic use, Drug Delivery Systems instrumentation, Influenza Vaccines immunology, Rotavirus Vaccines immunology, Vaccines, Virus-Like Particle immunology
- Published
- 2014
- Full Text
- View/download PDF
154. Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines.
- Author
-
Zang Y, Du D, Ge P, Xu Y, Liu X, Zhang Y, Su W, Kiseleva I, Rudenko L, Xu F, Kong W, and Jiang C
- Subjects
- Humans, Influenza Vaccines analysis, Reproducibility of Results, Sensitivity and Specificity, Vaccines, Attenuated standards, Influenza Vaccines standards, Orthomyxoviridae isolation & purification, Real-Time Polymerase Chain Reaction methods
- Abstract
Traditionally, infectivity of a trivalent live attenuated influenza vaccines (LAIVs) is titrated by determining the 50% egg infectious dose assay (EID50) or plaque forming units (PFU), which requires specific monoclonal antibodies to neutralize 2 strains while estimating the titer of the non-neutralized strain. Compared to this time-consuming, laborious, subjective and variable process, reverse transcription-quantitative real-time PCR (RT-qPCR) technology has advantages of rapidity, sensitivity, reproducibility and reduced contamination, thus has been applied widely for detecting pathogens and measuring viral titers. In this study, the critical harvest time was determined to be 18 h post-infection (hpi) for type A influenza and 12 hpi for type B influenza, but no significant difference between titers at 12 hpi and 18 hpi for the type B strain was observed. In conclusion, trivalent LAIVs can be titrated simultaneously within 24 h by this one-step RT-qPCR assay, which yielded titers comparable to those obtained by the traditional EID50 assay. Therefore, the RT-qPCR assay may be used as a highly specific, sensitive, precise and rapid alternative to the EID50 assay for titering LAIVs.
- Published
- 2014
- Full Text
- View/download PDF
155. Specificity in the actions of the UBR1 ubiquitin ligase in the degradation of nuclear receptors.
- Author
-
Sultana R, Theodoraki MA, and Caplan AJ
- Abstract
The UBR1 ubiquitin ligase promotes degradation of proteins via the N-end rule and by another mechanism that detects a misfolded conformation. Although UBR1 was shown recently to act on protein kinases whose misfolding was promoted by inhibition of Hsp90, it was unknown whether this ubiquitin ligase targeted other client types of the chaperone. We analyzed the role of UBR1 in the degradation of nuclear receptors that are classical clients of Hsp90. Our results showed that UBR1 deletion results in impaired degradation of the glucocorticoid receptor and the androgen receptor but not the estrogen receptor α. These findings demonstrate specificity in the actions of the UBR1 ubiquitin ligase in the degradation of Hsp90 clients in the presence of small molecule inhibitors that promote client misfolding.
- Published
- 2013
- Full Text
- View/download PDF
156. Amino acid determinants conferring stable sialidase activity at low pH for H5N1 influenza A virus neuraminidase.
- Author
-
Takahashi T, Nidom CA, Quynh Le MT, Suzuki T, and Kawaoka Y
- Abstract
Avian influenza A viruses (IAVs) and human 1918, 1957, and 1968 pandemic IAVs all have neuraminidases (NAs) that are stable at low pH sialidase activity, yet most human epidemic IAVs do not. We examined the pH stability of H5N1 highly pathogenic avian IAV (HPAI) NAs and identified amino acids responsible for conferring stability at low pH. We found that, unlike other avian viruses, most H5N1 IAVs isolated since 2003 had NAs that were unstable at low pH, similar to human epidemic IAVs. These H5N1 viruses are thus already human virus-like and, therefore, have the frequent infections of humans.
- Published
- 2012
- Full Text
- View/download PDF
157. Sorting signals
- Author
-
Breitfeld, P.P., Casanova, J.E., Simistert, N.E., Ross, S.A., McKinnon, W.C., and Mostov, K.E.
- Subjects
Cell Membrane ,M-6-P, mannose-6-phosphate ,Golgi Apparatus ,Membrane Proteins ,Proteins ,Biological Transport ,pig, polymeric immunoglobulin ,Endosomes ,Cell Biology ,Protein Sorting Signals ,Endoplasmic Reticulum ,Models, Biological ,Clathrin ,Endocytosis ,Article ,ER, endoplasmic reticulum ,LDL, low-density lipoprotein ,Animals ,RER, rough ER ,HA, hemagglutinin ,TGN, trans Golgi network - Published
- 1989
- Full Text
- View/download PDF
158. Induction of vacuolar Ca2+-ATPase and H+/Ca2+ exchange activity in yeast mutants lacking Pmr1, the Golgi Ca2+-ATPase
- Author
-
Marchi, Valerie, Sorin, Alexander, Wei, Ying, and Rao, Rajini
- Subjects
CCCP, carbonyl cyanide m-chlorophenylhydrazone ,SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis ,SERCA, sarco/endoplasmic reticulum Ca2+-ATPase ,Calcium homeostasis ,Saccharomyces cerevisiae ,H+/Ca2+ exchanger ,PMRI gene ,Ca2+-ATPase ,PMCI gene ,HA, hemagglutinin - Abstract
We have analyzed Ca2+ transport activity in defined subcellular fractions of an isogenic set of wild-type and mutant yeast. The results, together with measurements of polypeptide expression levels and promoter::reporter gene activity, show that the Golgi Ca2+-ATPase, Pmr1, is the major Ca2+ pump under normal growth conditions. In the absence of Pmr1, we show a massive, calcineurin-dependent compensatory induction of the vacuolar Ca2+-ATPase, Pmc1. In addition, H+/Ca2+ exchange activity, that may be distinct from the vacuolar exchanger Vcxl, is also increased.
- Full Text
- View/download PDF
159. A family of structurally related RING finger proteins interacts specificallly with the ubiquitin-conjugating enzyme UbcM4
- Author
-
Martinez-Noel, Gustavo, Niedenthal, Rainer, Tamura, Teruko, and Harbers, Klaus
- Subjects
UIP, UbcM4-interacting protein ,RING finger protein ,E1/Uba, ubiquitin-activating enzyme ,Protein-protein interaction ,PCR, polymerase chain reaction ,EST, expressed sequence tag ,Ubiquitin-conjugating enzyme ,E2/Ubc, ubiquitin-conjugating enzyme ,E3/Ubr, ubiquitin-protein ligase ,PAGE, polyacrylamide gel electrophoresis ,GFP, green fluorescent protein ,HA, hemagglutinin - Abstract
The ubiquitin-conjugating enzyme UbcM4 was previously shown to be necessary for normal mouse development. As a first step in identifying target proteins or proteins involved in the specificity of UbcM4-mediated ubiquitylation, we have isolated seven cDNAs encoding proteins that specifically interact with UbcM4 but with none of the other Ubes tested. This interaction was observed in yeast as well as in mammalian cells. With one exception, all UbcM4-interacting proteins (UIPs) belong to a family of proteins that contain a RING finger motif. As they are structurally related to RING finger proteins that have recently been shown to play an essential role in protein ubiquitylation and degradation, the possibility is discussed that UIPs are involved in the specific recognition of substrate proteins of UbcM4.
- Full Text
- View/download PDF
160. Recruitment of APPL1 to ubiquitin-rich aggresomes in response to proteasomal impairment
- Author
-
Lukasz Sadowski, Iwona Pilecka, Yannis Kalaidzidis, and Marta Miaczynska
- Subjects
Proteasome Endopeptidase Complex ,Aggresome ,Endosome ,Leupeptins ,NEDD4 ,Endosomes ,Cysteine Proteinase Inhibitors ,Endocytosis ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Ubiquitin ,MG132 ,Animals ,Humans ,APPL1 ,030304 developmental biology ,Adaptor Proteins, Signal Transducing ,GFP, green fluorescent protein ,Inclusion Bodies ,0303 health sciences ,biology ,MIP, maximal intensity projection ,Proteasome ,Ubiquitination ,Cell Biology ,APPL1, adaptor protein containing PH domain, PTB domain and leucine zipper motif ,Cell biology ,Ubiquitin ligase ,HEK293 Cells ,chemistry ,030220 oncology & carcinogenesis ,biology.protein ,EEA1, early endosome antigen 1 ,Proteasome Inhibitors ,HeLa Cells ,Research Article ,HA, hemagglutinin - Abstract
Inhibitors of proteasomes have been shown to affect endocytosis of multiple membrane receptors, in particular at the step of cargo sorting for lysosomal degradation. Here we demonstrate that the inhibition of proteasomes causes specific redistribution of an endosomal adaptor APPL1, which undergoes initial solubilization from APPL endosomes followed by clustering in the perinuclear region. MG132 treatment decreases APPL1 labeling of endosomes while the staining of the canonical early endosomes with EEA1 remains unaffected. Upon prolonged treatment with proteasome inhibitors, endogenous APPL1 localizes to the site of aggresome formation, with perinuclear APPL1 clusters encapsulated within a vimentin cage and co-localizing with aggregates positive for ubiquitin. The clustering of APPL1 is concomitant with increased ubiquitination and decreased solubility of this protein. We determined that the ubiquitin ligase Nedd4 enhances polyubiquitination of APPL1, and the ubiquitin molecules attached to APPL1 are linked through lysine-63. Taken together, these results add APPL1 to only a handful of endogenous cellular proteins known to be recruited to aggresomes induced by proteasomal stress. Moreover, our studies suggest that the proteasome inhibitors that are already in clinical use affect the localization, ubiquitination and solubility of APPL1.
- Full Text
- View/download PDF
161. Distribution of surface glycoproteins on influenza A virus determined by electron cryotomography
- Author
-
Tim Grant, Sebastian Wasilewski, Lesley J. Calder, and Peter B. Rosenthal
- Subjects
Models, Molecular ,Electron Microscope Tomography ,viruses ,Hemagglutinin (influenza) ,medicine.disease_cause ,RNP, ribonucleoprotein particle ,Virus ,Article ,Influenza A Virus, H2N2 Subtype ,RNP ,Viral Proteins ,M1, matrix protein ,Imaging, Three-Dimensional ,Viral envelope ,Immunology and Microbiology(all) ,Influenza A virus ,medicine ,Hemagglutinin ,Neuramindiase ,Ribonucleoprotein ,chemistry.chemical_classification ,Membrane Glycoproteins ,General Veterinary ,General Immunology and Microbiology ,biology ,Cryoelectron Microscopy ,Public Health, Environmental and Occupational Health ,Neutralizing antibody ,veterinary(all) ,Virology ,NA, neuraminidase ,Infectious Diseases ,chemistry ,Ectodomain ,biology.protein ,Biophysics ,Molecular Medicine ,Electron cryomicroscopy ,Glycoprotein ,Influenza virus ,Neuraminidase ,HA, hemagglutinin - Abstract
Highlights ► Cryotomography of influenza A virus reveals a polarized structure. ► 3D models for the virus envelope are built using glycoprotein X-ray structures. ► Inter-glycoprotein distances and fractional surface volumes are calculated. ► Accessibility of the HA stem domain to neutralizing antibodies is assessed. ► Viral membrane curvature may constrain interaction with a surface of receptors., We use electron cryotomography to reconstruct virions of two influenza A H3N2 virus strains. The maps reveal the structure of the viral envelope containing hemagglutinin (HA) and neuraminidase (NA) glycoproteins and the virus interior containing a matrix layer and an assembly of ribonucleoprotein particles (RNPs) that package the genome. We build a structural model for the viral surface by locating copies of the X-ray structure of the HA ectodomain into density peaks on the virus surface. We calculate inter-glycoprotein distances and the fractional volume occupied by glycoproteins. The models suggest that for typical HA densities on virus, Fabs can bind to epitopes on the HA stem domain. The models also show how membrane curvature may influence the number of glycoproteins that can simultaneously interact with a target surface of receptors.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.